A Case of Mycobacterium gordonae Pulmonary Disease in a Patient with Ulcerative Colitis Treated with Infliximab / 대한내과학회지
Korean Journal of Medicine
;
: 452-456, 2015.
Artículo
en Coreano
| WPRIM
| ID: wpr-153843
ABSTRACT
Tumor necrosis factor-alpha (TNF-alpha) is a key component of the host defense against mycobacterial infection. Mycobacterium gordonae (M. gordonae) is one of the least virulent mycobacteria, and is generally considered non-pathogenic if detected from a clinical specimen. Here, we report a rare case of pulmonary M. gordonae infection in a patient with ulcerative colitis who had been treated with infliximab, a TNF-alpha antagonist. M. gordonae infection was treated successfully with clarithromycin, rifampin, and ethambutol. We believe this to be the first report of M. gordonae pulmonary disease associated with TNF-alpha antagonist treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Rifampin
/
Úlcera
/
Colitis Ulcerosa
/
Factor de Necrosis Tumoral alfa
/
Claritromicina
/
Bacteria Gordonia
/
Etambutol
/
Infliximab
/
Enfermedades Pulmonares
/
Mycobacterium
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS